Exchange of Confidential Information. Confidential Information exchanged by the parties under this Agreement or any Study Agreement shall not constitute invalidating prior art with respect to any U.S. patent or U.S. patent application of a party in respect of an invention made as a result of activities undertaken within the scope of this Agreement or any Study Agreement.
Appears in 3 contracts
Samples: Study Agreement, Study Agreement (Juno Therapeutics, Inc.), Study Agreement (Juno Therapeutics, Inc.)
Exchange of Confidential Information. Confidential Information exchanged by the parties under this Agreement or any Study Agreement SOW shall not constitute invalidating prior art with respect to any U.S. patent or U.S. patent application of a party in respect of an invention made as a result of activities undertaken within the scope of this Agreement or any Study AgreementSOW.
Appears in 2 contracts
Samples: www.sec.gov, Juno Therapeutics, Inc.
Exchange of Confidential Information. Confidential Information exchanged by the parties under this Agreement or any Study Project Agreement shall not constitute invalidating prior art with respect to any U.S. patent or U.S. patent application of a party in respect of an invention made as a result of activities undertaken within the scope of this Agreement or any Study Project Agreement.
Appears in 1 contract
